Fear extinction and memory reconsolidation as critical components in behavioral treatment for posttraumatic stress disorder and potential augmentation of these processes

Neuroscience Letters

Volumn 649, Issue , 2017, Pages 170-175

  Smith, Noelle B ^a,b   Doran, Jennifer M ^c,d   Sippel, Lauren M ^c,d   Harpaz Rotem, Ilan ^c,d,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA Northeast Program Evaluation Center   (United States)

Author keywords

Extinction; Neurobiology; Posttraumatic stress disorder; Psychotherapy; Reconsolidation; Treatment

Indexed keywords

BEHAVIOR; COGNITIVE BEHAVIORAL THERAPY; CONDITIONING; EYE MOVEMENT DESENSITIZATION AND REPROCESSING; FEAR; FEAR EXTINCTION; HUMAN; INJURY; LONG TERM EXPOSURE; MEDICAL DEVICE; MEMORY CONSOLIDATION; MEMORY RECONSOLIDATION; NEUROBIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; ANIMAL; BRAIN; CONDITIONED REFLEX; DRUG EFFECTS; PATHOPHYSIOLOGY; PSYCHOLOGY; REINFORCEMENT;

ANIMALS; BRAIN; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; HUMANS; MEMORY CONSOLIDATION; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85009799077     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2017.01.006     Document Type: Review

References (95)

1. [1] Diener, S.J., Nees, N.F., Wessa, M., Wirtz, G., Frommberger, U., Penga, T., Ruttorf, M., Ruf, M., Schmahl, C., Flor, H., Reduced amygdala responsivity during conditioning to trauma related stimuli in posttraumatic stress disorder. Psychophysiology 53 (2016), 1460–1471.
2. [2] Myers, K.M., Davis, M., Mechanisms of fear extinction. Mol. Psychiatry 12 (2007), 120–150.
3. [3] Mahan, A.L., Ressler, K.J., Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci. 35 (2012), 24–35.
4. [4] Sherin, J.E., Nemeroff, C.B., Post-traumatic stress disorder: the neurobiological impact of psychological trauma. Dialogues Clin. Neurosci. 13 (2011), 263–278.
5. [5] Pietrzak, R.H., Averill, L.A., Abdallah, C.G., Neumeister, A., Krystal, J.H., Levy, I., Harpaz-Rotem, I., Amygdala-hippocampal volume and the phenotypic heterogeneity of posttraumatic stress disorder: a cross-sectional study. JAMA Psychiatry 72 (2015), 396–398.
6. [6] Rauch, S.L., Shin, L.M., Phelps, E.A., Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research—past, present, and future. Biol. Psychiatry 60 (2006), 376–382.
7. [7] Careaga, M., Loayza, B., Girardi, C.E.N., Suchecki, D., Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation. Neurosci. Biobehav. Rev. 71 (2016), 48–57.
8. [8] Wessa, M., Flor, H., Failure of extinction of fear responses in posttraumatic stress disorder: evidence from second-order conditioning. Am. J. Psychiatry 164 (2007), 1684–1692.
9. [9] Milad, M.R., Pitman, R.K., Ellis, C.B., Gold, A.L., Shin, L.M., Lasko, N.B., et al. Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol. Psychiatry 66 (2009), 1075–1082.
10. [10] Garfinkel, S.N., Abelson, J.L., King, A.P., Sripada, R.K., Wang, X., Gaines, L.M., Liberzon, I., Impaired contextual modulation of memories in PTSD: an fMRI and psychophysiological study of extinction retention and fear renewal. J. Neurosci. 34:40 (2014), 13435–13443.
11. [11] Wicking, M., Steiger, F., Nees, F., Diener, S.J., Grimm, O., Ruttorf, M., Schad, L.R., Winkelmann, T., Wirtz, G., Flor, H., Deficient fear extinction memory in posttraumatic stress disorder. Neurobiol. Learn. Mem. 136 (2016), 116–126.
12. [12] Nader, K., Schafe, G.E., Le Doux, J.E., Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406 (2000), 722–726.
13. [13] Przybyslawski, J., Sara, S.J., Reconsolidation of memory after its reactivation. Behav. Brain Res. 84 (1997), 241–246.
14. [14] Marks, E.H., Zoellner, L.A., Attenuating fearful memories: effect of cued extinction on intrusions. Emotion 14 (2014), 1143–1154.
15. [15] Debiec, J., LeDoux, J.E., Nader, K., Cellular and systems reconsolidation in the hippocampus. Neuron 36 (2002), 527–538.
16. [16] Agren, T., Engman, J., Frick, A., Björkstrand, J., Larsson, E.M., Furmark, T., Fredrikson, M., Disruption of reconsolidation erases a fear memory trace in the human amygdala. Science 337 (2012), 1550–1552.
17. [17] Dekel, S., Solomon, Z., Ein-Dor, T., PTSD symptoms lead to modification in the memory of the trauma: a prospective study of former prisoners of war. J. Clin. Psychiatry 77 (2016), 290–296.
18. [18] Weems, C.F., Russell, J.D., Banks, D.M., Graham, R.A., Neill, E.L., Scott, B.G., Memories of traumatic events in childhood fade after experiencing similar less stressful events: results from two natural experiments. J. Exp. Psychol.: Gen. 143:5 (2014), 2046–2055.
19. [19] Lane, R.D., Ryan, L., Nadel, L., Greenberg, L., Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: new insights from brain science. Behav. Brain Sci., 38, 2015, e1.
20. [20] Schiller, D., Monfils, M.H., Raio, C.M., Johnson, D.C., LeDoux, J.E., Phelps, E.A., Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 463 (2010), 49–53.
21. [21] Cusack, K., Jonas, D.E., Forneris, C.A., Wines, C., Sonis, J., Middleton, J.C., Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 43 (2016), 128–141.
22. [22] Lee, D.J., Schnitzlein, C.W., Wolf, J.P., Vythilingam, M., Rasmusson, A.M., Hoge, C.W., Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depression, 2016 Epub ahead of print.
23. [23] Bisson, J.I., Roberts, N.P., Andrew, M., Cooper, R., Lewis, C., Psychological therapies for chronic posttraumatic stress disorder (PTSD) in adults. Cochrane Database Syst. Rev. 12 (2013), 1–241.
24. [24] American Psychiatric Association, Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am. J. Psychiatry, 161, 2004, 11.
25. [25] Institute of Medicine, Treatment of Posttraumatic Stress Disorder: An Assessment of the Evidence. 2017, National Academy Press, 2008.
26. [26] E.B. Foa, E.A., Hembree, B.O. Rothbaum, Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences (therapist guide). Oxford, New York, 2007.
27. [27] Shapiro, F., Eye movement desensitization and reprocessing: basic principles, protocols, and procedures. Encycl. Psychother. 1 (1995), 777–785.
28. [28] Erickson, H.J., Hurley, R.A., Taber, K., Psychotherapy for PTSD: neuroimaging of recovery processes. J. Neuropsychiatry Clin. Neurosci. 26:3 (2014), iv–195.
29. [29] Zantvoord, J.B., Diehle, J., Lindauer, R.J.L., Using neurobiological measures to predict and assess treatment outcome of psychotherapy in posttraumatic stress disorder: systematic review. Psychother. Psychosom. 82 (2013), 142–151.
30. [30] Thomaes, K., Dorrepaal, E., Draijer, N., Jansma, E.P., Veltman, D.J., van Balkom, A.J., Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review. J. Psychiatry Res. 50 (2014), 1–15.
31. [31] Rubin, M., Shvil, E., Papini, S., Chhetry, B.T., Helpman, L., Markowitz, J.C., Mann, J.J., Neria, Y., Greater hippocampal volume is associated with PTSD treatment response. Psychiatry Res. 252 (2016), 36–39.
32. [32] Echiverri-Cohen, A., Zoellner, L.A., Gallop, R., Feeny, N., Jaeger, J., Bedard-Gilligan, M., Changes in temporal attention inhibition following Prolonged Exposure and sertraline in the treatment of PTSD. J. Consult. Clin. Psychol. 84 (2016), 415–426.
33. [33] Helpman, L., Papini, S., Chhetry, B.T., Shvil, E., Rubin, M., Sullivan, G.M., Markowitz, J.C., Mann, J.J., Neria, Y., PTSD remission after Prolonged Exposure treatment is associated with anterior cingulate cortex thinning and volume reduction. Depress. Anxiety 33 (2016), 384–391.
34. [34] Etkin, A., Egner, T., Peraza, D.M., Kandel, E.R., Hirsch, J., Resolving emotional conflicts: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron 51 (2006), 871–882.
35. [35] Karl, A., Schaefer, M., Malta, L.S., Dorfel, D., Rohleder, N., Werner, A., A meta-analysis of structural brain abnormalities in PTSD. Neurosci. Biobehav. Rev. 30 (2006), 1004–1031.
36. [36] Helpman, L., Marin, M.F., Papini, S., Zhu, X., Sullivan, G.M., Schneier, F., Nerial, M., Neural changes in extinction recall following prolonged exposure treatment for PTSD: a longitudinal fMRI study. NeuroImage: Clin. 12 (2016), 715–723.
37. [37] Levy-Gigi, E., Szabó, C., Kelemen, O., Kéri, S., Association among clinical response, hippocampal volume, and FKBP5 gene expression in individuals with posttraumatic stress disorder receiving cognitive behavioral therapy. Biol. Psychiatry 74:11 (2013), 793–800.
38. [38] Bryant, R.A., Felmingham, K., Whitford, T.J., Kemp, A., Hughes, G., Peduto, A., Williams, L.M., Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. J. Psychiatry Neurosci. 33:2 (2008), 142–146.
39. [39] Felmingham, K., Kemp, A., Williams, L., Das, P., Hughes, G., Peduto, A., Bryant, R., Changes in anterior cingulate and amygdala after cognitive behavior therapy of posttraumatic stress disorder. Psychol. Sci. 18:2 (2007), 127–129.
40. [40] van Rooij, S.J.H., Geuze, E., Kennis, M., Rademaker, A.R., Vink, M., Neural correlates of inhibition and contextual cue processing related to treatment response in PTSD. Neuropsychopharmacology 40:3 (2015), 667–675.
41. [41] Boccia, M., Piccardi, L., Cordellieri, P., Guariglia, C., Giannini, A.M., EMDR therapy for PTSD after motor vehicle accidents: Meta-analytic evidence for specific treatment. Front. Hum. Neurosci. 9 (2015), 1–9.
42. [42] Lansing, K., Amen, D.G., Hanks, C., Rudy, L., High-resolution brain SPECT imaging and eye movement desensitization and reprocessing in police officers with PTSD. J. Neuropsychiatry Clin. Neurosci. 17 (2005), 526–532.
43. [43] Bossini, L., Tavanti, M., Calossi, S., Polizzotto, N.R., Vatti, G., Marino, D., Castrogiovanni, P., EMDR treatment for posttraumatic stress disorder, with focus on hippocampal volumes: a pilot study. J. Neuropsychiatry Clin. Neurosci. 23:2 (2011), E1–E2.
44. [44] Laugharne, J., Kullack, C., Lee, C.W., McGuire, T., Brockman, S., Drummond, P.D., Starkstein, S., Amygdala volumetric change following psychotherapy for posttraumatic stress disorder. J. Neuropsychiatry Clin. Neurosci., 2016 Epub ahead of print.
45. [45] Pagani, M., Högberg, G., Fernandez, I., Siracusano, A., Correlates of EMDR therapy in functional and structural neuroimaging: a critical summary of recent findings. J. EMDR Pract. Res. 7:1 (2013), 29–38.
46. [46] Fitzgerald, P.J., Seemann, J.R., Maren, S., Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res. Bull. 105 (2014), 46–60.
47. [47] Craske, M., Treanor, M., Conway, C.C., Zbozinek, T., Vervliet, B., Maximizing exposure therapy: an inhibitory learning approach. Behav. Res. Ther. 58 (2014), 10–23.
48. [48] Forcato, C., Bavassi, L., De Pino, G., Fernández, R.S., Villarreal, M.F., Pedreira, M.E., Differential left hippocampal activation during retrieval with different types of reminders: an fMRI study of the reconsolidation process. PLoS One 11:3 (2016), 1–14.
49. [49] Dunbar, A.B., Taylor, J.R., Reconsolidation and psychopathology: moving towards reconsolidation-based treatments. Neurobiol. Learn. Mem., 2016.
50. [50] Högberg, G., Nardo, D., Hällström, T., Pagani, M., Affective psychotherapy in post-traumatic reactions guided by affective neuroscience: memory reconsolidation and play. Psychol. Res. Behav. Manage. 4 (2011), 87–96.
51. [51] Drexler, S.M., Merz, C.J., Hamacher-Dang, T.C., Tegenthoff, M., Wolf, O.T., Effects of cortisol on reconsolidation of reactivated fear memories. Neuropsychopharmacology, 2015, 3036–3043.
52. [52] Bradley, R., Greene, J., Russ, E., Dutra, L., Westen, D., A multidimensional meta-analysis of psychotherapy for PTSD. Am. J. Psychiatry 162 (2005), 214–227.
53. [53] Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., Ressler, K.J., Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol. Ther. 149 (2015), 150–190.
54. [54] Dunlop, B.W., Manson, E., Gerardi, M., Pharmacological innovations for posttraumatic stress disorder and medication-enhanced psychotherapy. Curr. Pharm. Des. 18 (2012), 5645–5658.
55. [55] de Kleine, R.A., Rothbaum, B.O., van Minnen, A., Pharmacological enhancement of exposure-based treatment in PTSD: A qualitative review. Eur. J. Psychotraumatol., 4, 2013.
56. [56] Davis, M., Myers, K.M., The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biol. Psychiatry 52:10 (2002), 998–1007.
57. [57] Norberg, M.M., Krystal, J.H., Tolin, D.F., A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol. Psychiatry 63 (2008), 1118–1126.
58. [58] Difede, J., Cukor, J., Wyka, K., Olden, M., Hunter, H., Lee, F.S., Altemus, M., D-Cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial. Neuropsychopharmacology 39 (2014), 1052–1058.
59. [59] de Kleine, R.A., Hendriks, G.-J., Kusters, W.J.C., Broekman, T.G., van Minnen, A., A randomized placebo-controlled trial of D-Cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biol. Psychiatry 96 (2012), 962–968.
60. [60] Rothbaum, B.O., Price, M., Jovanovic, T., Norrholm, S.D., Gerardi, M., Dunlop, B., Davis, M., Bradley, B., Duncan, E.J., Rizzo, A., Ressler, K.J., A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. Am. J. Psychiatry 171 (2014), 640–648.
61. [61] Litz, B.T., Salters-Pedneault, K., Steenkamp, M.M., Hermos, J.A., Bryant, R.A., Otto, M.W., Hofmann, S.G., A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J. Psychiatry Res. 46 (2012), 1184–1190.
62. [62] de Kleine, R.A., Smits, J.A.J., Hendriks, G.-J., Becker, E.S., van Minnen, A., Extinction learning as a moderator of D-Cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder. J. Anxiety Disord. 34 (2015), 63–67.
63. [63] Holmes, A., Quirk, G.J., Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders-the case of yohimbine. Trends Pharmacol. Sci. 31:1 (2010), 2–7.
64. [64] Wangelin, B.C., Powers, M.B., Smits, J.A.J., Tuerk, P.W., Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome. Contemp. Clin. Trials 36:2 (2013), 319–326.
65. [65] Wrubel, K.M., Riha, P.D., Maldonado, M.A., McCollum, D., Gonzalez-Lima, F., The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacol. Biochem. Behav. 86:4 (2007), 712–717.
66. [66] Yehuda, R., Bierer, L.M., Pratchett, L., Malowney, M., Glucocorticoid augmentation of prolonged exposure therapy: rationale and case report. Eur. J. Trauma, 1, 2010.
67. [67] Suris, A., North, C., Adinoff, B., Powell, C.M., Greene, R., Effects of exogenous glucocorticoid on combat-related PTSD symptoms. Ann. Clin. Psychiatry 22:4 (2010), 274–279.
68. [68] Zhang, L.-M., Zhou, W.-W., Ji, Y.-J., Li, Y., Zhao, N., Chen, H.-X., Xue, R., Mei, X.-G., Zhang, Y.-Z., Wang, H.-L., Li, Y.-F., Anxiolytic effects of ketamine in animal models of posttraumatic stress disorder. Psychopharmacology 232:4 (2015), 663–672.
69. [69] Duman, R.S., Rong-Jian Liu, N.L., Duric, V., Aghajanian, G., Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 62:1 (2012), 35–41.
70. [70] Feder, A., Parides, M.K., Murrough, J.W., Perez, A.M., Morgan, J.E., Saxene, S., Kirkwood, K., aan het Rot, M., Lapidus, K.A.B., Wan, L.-B., Iosifescu, D., Charney, D.S., Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry 71:6 (2014), 681–688.
71. [71] Brunet, A., Orr, S.P., Tremblay, J., Robertson, K., Nader, K., Pitman, R.K., Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J. Psychiatry Res. 42:6 (2008), 503–506.
72. [72] Brunet, A., Poundja, J., Tremblay, J., Bui, E., Thomas, E., Orr, S., Azzoug, A., Birmes, P., Pitman, R.K., Trauma reactivation under the influence of propranolol decreases posttraumatic stress symptoms and disorder: 3 open-label trials. J. Clin. Psychopharm. 31:4 (2011), 547–550.
73. [73] Glover, E.M., Ressler, K.J., Davis, M., Differing effects of systemically administered rapamycin on consolidation and reconsolidation of context vs. cued fear memories. Learn. Mem. 17 (2010), 577–581.
74. [74] Alberini, M., LeDoux, J.E., Memory reconsolidation. Curr. Biol. 23:17 (2013), 746–750.
75. [75] Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, L., Martin, S.F., Yazar-Klosinski, B., Michel, Y., Brewerton, T.D., Doblin, R., Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-mehylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow up study. J. Psychopharmacol. 27:1 (2012), 28–39.
76. [76] Oehen, P., Traber, R., Widmer, V., Schnyder, U., A randomized, controlled pilot study of MDMA (±3, 4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD). J. Psychopharmacol. 27:1 (2013), 40–52.
77. 15O]-PET in healthy humans. Neuropsychopharmacology 23 (2000), 388–395.
78. [78] Olff, M., Langeland, W., Witteveen, A., Denys, D., A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectr. 15:8 (2010), 522–553.
79. [79] Acheson, D., Feifel, S., de Wilde, R., Mckinney, J., Lohr, J., Risbrough, V., The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology 229 (2013), 199–208.
80. [80] Koch, S.B.J., van Zuiden, M., Nawijn, L., Frijling, J.L., Veltman, D.J., Olff, M., Intranasal oxytocin administration dampens amygdala reactivity towards emotional faces in male and female PTSD patients. Neuropsychopharmacology 41 (2015), 1495–1504.
81. [81] Koch, S.B., van Zuiden, M., Nawijn, L., Frijling, J.L., Veltman, D.J., Olff, M., Intranasal oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology 41 (2016), 2041–2051.
82. [82] Marin, M.-F., Camprodon, J.A., Dougherty, D.D., Milad, M.R., Device-based brain stimulation to augment fear extinction: implications for PTSD treatment and beyond. Depress. Anxiety 26 (2010), 269–278.
83. [83] Reznikov, R., Binko, M., Nobrega, J.N., Hamani, C., Deep brain stimulation in animal models of fear, anxiety, and posttraumatic stress disorder. Neuropsychopharmacology, 2016, 2810–2817.
84. [84] George, M.S., Sackeim, H.A., Rush, A.J., Marangell, L.B., Nahas, Z., Husain, M.M., Lisanby, S., Burt, T., Goldman, J., Ballenger, J.C., Vagus nerve stimulation: a new tool for brain research and therapy. Biol. Psychiatry 47:4 (2000), 287–295.
85. [85] Delgado, M.R., Nearing, K.I., Ledoux, J.E., Phelps, E.A., Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 59:5 (2008), 829–838.
86. [86] Asthana, M., Nueckel, K., Mühlberger, A., Neueder, D., Polak, T., Domschke, K., Deckert, J., Herrmann, M.J., Effects of transcranial direct current stimulation on consolidation of fear memory. Front. Psychiatry 4 (2013), 1–7.
87. [87] Gisquet-Verrier, P., Lynch, J.F., Cutolo, P., Toledano, D., Ulmen, A., Jasnow, A.M., Riccio, D.C., Integration of new information with active memory accounts for retrograde amnesia: a challenge to the consolidation/reconsolidation hypothesis?. J. Neurosci. 35:33 (2015), 11623–11633.
88. [88] Clem, R.L., Schiller, D., New learning and unlearning: strangers or accomplices in threat memory attenuation?. Trends Neurosci., 2016, 1–12 ePub.
89. [89] Fiorenza, N.G., Sartor, D., Myskiw, J.C., Izquierdo, I., Treatment of fear memories: interactions between extinction and reconsolidation. An. Acad. Bras. Cienc. 83:4 (2011), 1363–1372.
90. [90] Costanzi, M., Cannas, S., Saraulli, D., Rossi-Arnaud, C., Cestari, V., Extinction after retrieval: effects on the associative and nonassociative components of remote contextual fear memory. Learn. Mem. 18 (2011), 508–518.
91. [91] Fricchione, J., Greenberg, M.S., Spring, J., Wood, N., Mueller, C., Pfeiffer, M.R., Milad, M.R., et al. Delayed extinction fails to reduce skin conductance reactivity to fearconditioned stimuli. Psychophysiology, 2016, 1343–1351.
92. [92] Kimbrel, N.A., Meyer, E.C., Beckham, J.C., A clinician's perspective on memory reconsolidation as the primary basis for psychotherapeutic change in PTSD. Behav. Brain. Sci., 38, 2015, e8.
93. [93] Thomaes, K., Dorrepaal, E., Draijer, N., De Ruiter, M.B., Elzinga, B.M., Van Balkom, A.J., Smit, J.H., Veltman, D.J., Treatment effects on insular and anterior cingulate cortex activation during classic and emotional Stroop interference in child abuse-related complex post-traumatic stress disorder. Psychol. Med. 42:11 (2012), 2337–2349.
94. [94] Markowitz, J.C., Petkova, E., Neria, Y., Van Meter, P.E., Zhao, Y., Hembree, E., et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am. J. Psychiatry 172 (2015), 430–440.
95. [95] Parsons, R.G., Ressler, K.J., Implications of memory modulation for post-traumatic stress and fear disorders. Nat. Neurosci. 16:2 (2013), 146–153.